Maurer J R, Chaparro C
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic Foundation, OH 44195, USA.
Curr Opin Pulm Med. 1995 Nov;1(6):465-70. doi: 10.1097/00063198-199511000-00006.
Since the mid-1980s, more than 500 isolated lung and more than 240 heart-lung transplantations have been performed in patients with cystic fibrosis and end-stage disease. Survival data in these patients are now comparable to those of the general transplantation population as physicians have learned to deal successfully with many issues unique to patients with cystic fibrosis. Resistant infections and bronchiolitis obliterans remain significant obstacles to overcome in order to improve patients outcomes and enhance posttransplant quality of life.
自20世纪80年代中期以来,已经为患有囊性纤维化和终末期疾病的患者进行了500多例单肺移植以及240多例心肺移植。由于医生们已经学会成功应对许多囊性纤维化患者特有的问题,这些患者的生存数据现在与一般移植人群的生存数据相当。为了改善患者的预后并提高移植后的生活质量,耐药感染和闭塞性细支气管炎仍然是需要克服的重大障碍。